SHH and central nervous system neoplasm: Together, these advances recently culminated in the recognition of MB subgroups as part of the WHO Classification of CNS tumors [17, 24], which currently recognizes four molecular variants of the disease (WNT, SHH-TP53wild type, SHH-TP53mut, and non-WNT/non-SHH).